Written by 5:07 pm A-popular blogs, ASX, Australia, Featured Business News, Home Top Stories, Homepage, Investment News, Latest, Latest News, Most Popular, News, Pin Top Story, Popular Blogs, Top Stories, Top Story, Trending News

Dexus finishes its $2 billion divestment a year early

Dexus (ASX: DXS) has exchanged contracts on three office towers for $715 million, tipping its two-year sell-down past $2 billion before FY27 even starts.

Dexus told the market on 27 July 2026 that it had sold 30-34 Hickson Road and 36 Hickson Road in Sydney, plus 123 Albert Street in Brisbane. The combined price matched independent valuations at 30 June 2026.

Against the December 2025 book values, though, the properties went for roughly 4% less. That gap is the whole story.

Selling below book is not failure here. It is the cost of getting out. And Dexus decided the cost was worth paying now rather than waiting for a recovery that keeps not arriving on schedule.

The Dexus $715 million office sale tells you what the buildings are worth empty

Look at what actually changed hands. One of the two Hickson Road towers, the A grade building at 30-34, was 41% occupied by area with a weighted average lease expiry of 0.7 years. That is a building running close to half empty with tenants nearly out the door.

The three towers Dexus sold, from a near-half-empty A grade Sydney building to a well-leased Brisbane premium tower. Occupancy by area and WALE by income are as at 31 December 2025.

CEO Ross Du Vernet framed the round as proof of discipline. His words: the deals show the group can “secure liquidity at pricing which represents a significant premium to what is implied in the Dexus security price.”

Translate that. The stock trades at a discount to what the property underneath is worth. Selling near valuation, even at a 4% haircut to book, still beats the number the market has been slapping on Dexus shares. So the company is quietly arbitraging its own listed price by turning bricks into cash.

That is a defensible move. It is also an admission. If your own buildings are worth more sold than held inside your listed vehicle, the market is telling you something about how it rates your management premium.

Why the deferred payment matters more than the headline number

Here is the detail most coverage will skip. Settlement lands in October 2026, subject to conditions including FIRB approval. But Dexus only collects about 67% of the price up front. The other 33% sits deferred for 30 months, earning a 6.25% annual coupon.

So a third of that $715 million is really vendor finance. Dexus is lending the buyer part of the purchase price and getting paid interest to wait.

That tells you plenty about the buyer pool for half-empty city towers. Cash buyers willing to write one cheque are thin. To move the assets, the seller sweetens the terms. The 6.25% coupon is decent compensation, but it means the balance sheet benefit arrives in stages, not all at once.

Sale proceeds on settlement trim pro forma look-through gearing by around 2 percentage points. Useful. Gearing sat at 33.9% at the last half, up from 31.7% six months earlier, so shaving it back has real value. Just don’t expect the full clean-up in October.

Dexus cleared its circa $2 billion divestment target ahead of FY27 after the latest $715 million office round. [Dexus ASX announcements]

Dexus real estate portfolio sale 2026 fits a much longer retreat from office

None of this started in 2024. Dexus has offloaded $7.4 billion of assets over five years. The plan was always to shift weight away from owning office towers on its own balance sheet and toward managing other people’s money for a fee.

The maths shows it working. Funds management ran about 7% of funds from operations in FY19. By late 2025 it was around a quarter, helped by the 2023 pickup of AMP Capital’s domestic real estate and infrastructure funds. Dexus wants that closer to 30% over time.

Office is the part being shrunk. The June 2026 revaluation across 175 assets came in at a 0.2% dip overall, with office down about 0.4% and industrial up around 0.5%. Values are stabilising, not rebounding. Sydney holds up better than most, which is exactly where two of these three sold towers sat.

Sell the weak office stock, keep the industrial, grow the fee business. That is the trade Dexus is making, and the $715 million round is one more brick pulled out of the office wall.

Worth checking the current Dexus share price and market data against these figures, since live pricing shifts daily and matters for any valuation call.

For readers weighing where property trusts sit right now, we have covered the top ASX real estate stocks by market cap and how global REITs are adapting to the interest rate cycle. The passive income angle on A-REITs is also relevant, given Dexus trades on a yield above 6% off a price sitting below net asset value.

What a reader should actually take from this

The takeaway is not “Dexus hit its target early, buy the stock.” The takeaway is that Dexus proved it can sell distressed office at close to carrying value in a soft market, using deferred terms to get deals over the line.

That de-risks the balance sheet story. It does not fix the demand story for office, and it does not close the gap between the share price and the underlying asset value on its own.

The 4% discount to book is the honest number. If the rest of the office portfolio clears at similar levels, the writedowns are manageable. If the buyer pool keeps demanding vendor finance to transact, patience becomes the real cost.

Analysts are split, with at least one carrying a Sell and a $6.40 target while the stock trades north of $7. That spread is the argument in a nutshell. Dexus is executing its plan cleanly. Whether the plan is enough depends on office, and office is still finding its floor.

Also Read: ASX Dividend Stocks in 2026: When Cash Fights Back

FAQs

Q: What did Dexus sell?
A:
  Two Sydney office towers on Hickson Road and one Brisbane tower at 123 Albert Street, for $715 million combined.

Q: Did Dexus sell at a profit?
A:
  The price matched June 2026 valuations but sat about 4% below December 2025 book values.

Q: How much does Dexus receive at settlement?
A:
  Around 67% up front, with 33% deferred for 30 months at a 6.25% annual coupon.

Q: When does the sale settle?
A:
  October 2026, subject to conditions including FIRB approval.

Q: What was the divestment target?
A:
  About $2 billion across FY25 to FY27. The latest round pushed the total past that mark early.

Q: How does it affect gearing?
A:
Settlement is expected to cut pro forma look-through gearing by roughly 2 percentage points.

Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Colitco is not a licensed financial advisor. The figures cited are drawn from Dexus’s ASX announcement dated 27 July 2026 and other referenced sources, and some data such as live share prices requires independent verification. Readers should conduct their own research and consult a licensed financial professional before making any investment decision. Investing in shares carries risk, including the loss of capital.

Source: https://yourir.info/resources/213040217ce6b79e/announcements/dxs.asx/2A1685911/DXS_Dexus_completes_$2_billion_divestment_program_ahead_of_FY27.pdf

 

Luke Carlino
+ posts

Luke Carlino is a seasoned Copywriter, Content Strategist, and Social Media Manager specialising in Mining, Finance, and Business journalism. With more than a decade of industry experience, he brings rigorous editorial standards and commercial acuity to every project.

Tags: , , , , Last modified: July 27, 2026
Close Search Window
Close